NEUROASPIS

Neuroaspis is a specialized biotechnology and nutraceutical company focused on developing advanced dietary interventions for neurodegenerative diseases, particularly Multiple Sclerosis (MS). The company's flagship product, Neuroaspis PLP10, is a patented oral formulation consisting of specific omega-3 and omega-6 polyunsaturated fatty acids combined with antioxidant vitamins. Clinical research, including Phase II trials, has demonstrated the formulation's potential to reduce the annual relapse rate and disease progression in patients with Relapsing-Remitting Multiple Sclerosis. Neuroaspis operates primarily through partnerships for the distribution and clinical validation of its lipid-based therapeutic approach.